Clinical trial finds finerenone reduces worsening heart failure and cardiovascular death

Estimated reading time: 1 minutes

• About The Author

Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.

About The Author

See author's posts

Trending

The Ultimate Guide to Instagram Influencer Marketing for Brands